Pediatrix Medical Group, Inc. - 10-Q Summary (Period Ended June 30, 1998)
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Pediatrix Medical Group, Inc., covering the three and six months ended June 30, 1998. The Company operates as a physician group practice specializing in pediatric care. As of August 6, 1998, there were 15,242,831 shares of common stock outstanding.
Key Financial Metrics
| Metric | Six Months Ended June 30, 1998 | Six Months Ended June 30, 1997 |
|---|---|---|
| Net Patient Service Revenue | $83,952,000 | $57,612,000 |
| Net Income | $13,226,000 | $9,076,000 |
| Income from Operations | $21,907,000 | $13,978,000 |
| Net Cash Provided by Operating Activities | $9,655,000 | $8,755,000 |
| Net Cash Used in Investing Activities | ($38,248,000) | ($1,986,000) |
| Cash and Cash Equivalents (End of Period) | $1,753,000 | $27,369,000 |
| Working Capital | $15,900,000 | $53,900,000 (Dec 31, 1997) |
| Debt (Line of Credit + Notes) | $12,650,000 | $2,750,000 (Dec 31, 1997) |
| Net Income Margin | 15.8% | 15.8% |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 45.7% year-over-year for the six-month period. Approximately 93.9% of this increase ($24.8 million) was attributable to new units acquired, while same-unit revenue grew 5.2%.
- Acquisition Activity: The Company acquired 10 physician group practices in the first six months of 1998 for approximately $62 million in cash and 4.1 million shares of subsidiary stock. This drove a significant increase in depreciation and amortization expenses (up 112.9%) and salaries (up 39.5%).
- Liquidity Shift: Cash and cash equivalents decreased by $16.8 million to $1.75 million due to heavy investment in acquisitions ($63.9 million in acquisition payments). To fund these activities, the Company utilized a $10 million line of credit.
- Investment Income: Investment income dropped significantly (from $1.3 million to $0.5 million) as funds previously held in marketable securities were deployed for acquisitions.
Outlook, Risks, and Management Commentary
- Liquidity Outlook: Management anticipates that funds generated from operations, combined with the existing credit facility, will be sufficient to meet working capital requirements and finance capital expenditures for at least the next twelve months.
- Legal Contingencies: The Company is involved in pending medical malpractice actions, which are generally covered by insurance. Management does not expect these to have a material impact on financial position or liquidity.
- Tax Matters: The IRS concluded its examination of tax years 1992-1994 in 1998 with no material effect on the Company's financials.
- Pro Forma Data: Pro forma results for the six months ended June 30, 1998, assuming acquisitions occurred on Jan 1, 1997, show net income of $13.4 million and diluted EPS of $0.85.
Investor Verification Checklist
- Cash Position: Verify the sustainability of operations with only $1.75 million in cash on hand despite $10 million in available credit.
- Acquisition Integration: Assess the performance of the 10 new physician groups acquired in H1 1998 to ensure they meet projected revenue and margin targets.
- Debt Covenants: Review the terms of the $10 million line of credit and note payables to ensure compliance with covenants given the shift in liquidity.
- Goodwill Amortization: Monitor the impact of the $62 million acquisition cost on future earnings via the 25-year straight-line amortization of goodwill.